Orphan Drugs Market Research: Expansive Analysis on Rare Disease Treatments and Global Forecast Through 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Markets for Orphan Drugs” report has been added to ResearchAndMarkets.com’s offering. Revealing... Read more.
Pantheon completes largest-ever fundraise with $5.3bn close of secondaries-focused infrastructure program
Total aggregate fundraising for Pantheon Global Infrastructure Fund IV and associated vehicles (PGIF IV) equates to largest-ever program, and exceeded initial target... Read more.
GeoPark Announces Fourth Quarter 2023 Operational Update
Quarterly Production up 10% With More Exploration Successes Shareholder Returns Exceeded Full-year Targets BOGOTA, Colombia–(BUSINESS WIRE)–GeoPark Limited... Read more.
MidOcean Partners Makes a Significant Investment in The Re-Sourcing Group, a Leading Professional Services Firm Specializing in Finance & Accounting, Compliance, and IT
NEW YORK–(BUSINESS WIRE)–MidOcean Partners (“MidOcean”), a premier New York-based alternative asset manager specializing in middle-market private... Read more.
Bob Evans Selects PAR Technology’s Punchh® to Enhance Guest Experience and Loyalty
America’s Favorite Farm Fresh Restaurant Chain Brings Personal Touch to Dining Experiences with PAR Punchh’s Loyalty Platform NEW HARTFORD, N.Y.–(BUSINESS... Read more.
Eaton Appoints Board Member, Olivier Leonetti, Executive Vice President and Chief Financial Officer; Expects Strong Fourth Quarter and Full-Year 2023 Results
DUBLIN–(BUSINESS WIRE)–Intelligent power management company Eaton (NYSE: ETN) announced today that Olivier Leonetti has been named executive vice president... Read more.
Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer
DALLAS–(BUSINESS WIRE)–Starlight Therapeutics— a Lantern Pharma (Nasdaq: LTRN) subsidiary focused exclusively on the clinical development of therapies... Read more.
Schwab Reports Fourth Quarter and Full Year Results
December Core Net New Assets Exceed $40 Billion – Annualized Growth Rate of 6% Total Client Assets Reach Record $8.5 Trillion at Year-end, Up 21% WESTLAKE, Texas–(BUSINESS... Read more.
Online Writing Effective Pharma Standard Operating Procedures (SOP) Seminar – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “SOP Synergy 2023 – Writing Effective Standard Operating Procedures Seminar” training has been added to... Read more.
Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform
Innovative Technology Accurately Detects Cancer Based on Analysis of Changes to Protein Structure Novo Holdings led growth capital financing CLEVELAND–(BUSINESS... Read more.